omniture
logo
Search
盟科药业
Media Room

Photo News

rss
MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia

MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia

2024-10-25 19:29 1385
MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum

MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum

2024-10-18 22:09 1321
MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections

MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections

2024-10-08 13:38 1040
MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference

MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference

2024-07-18 13:19 1332
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

2023-09-22 16:41 1470
Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc.

Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc.

2023-02-08 16:05 2457